Association between regional body fat and cardiovascular disease risk among postmenopausal women with normal body mass index.

AIMS Central adiposity is associated with increased cardiovascular disease (CVD) risk, even among people with normal body mass index (BMI). We tested the hypothesis that regional body fat deposits (trunk or leg fat) are associated with altered risk of CVD among postmenopausal women with normal BMI. METHODS AND RESULTS We included 2683 postmenopausal women with normal BMI (18.5 to <25 kg/m2) who participated in the Women's Health Initiative and had no known CVD at baseline. Body composition was determined by dual energy X-ray absorptiometry. Incident CVD events including coronary heart disease and stroke were ascertained through February 2017. During a median 17.9 years of follow-up, 291 incident CVD cases occurred. After adjustment for demographic, lifestyle, and clinical risk factors, neither whole-body fat mass nor fat percentage was associated with CVD risk. Higher percent trunk fat was associated with increased risk of CVD [highest vs. lowest quartile hazard ratio (HR) = 1.91, 95% confidence interval (CI) 1.33-2.74; P-trend <0.001], whereas higher percent leg fat was associated with decreased risk of CVD (highest vs. lowest quartile HR = 0.62, 95% CI 0.43-0.89; P-trend = 0.008). The association for trunk fat was attenuated yet remained significant after further adjustment for waist circumference or waist-to-hip ratio. Higher percent trunk fat combined with lower percent leg fat was associated with particularly high risk of CVD (HR comparing extreme groups = 3.33, 95% CI 1.46-7.62). CONCLUSION Among postmenopausal women with normal BMI, both elevated trunk fat and reduced leg fat are associated with increased risk of CVD.

[1]  B. Nordestgaard,et al.  Liver fat content, non-alcoholic fatty liver disease, and ischaemic heart disease: Mendelian randomization and meta-analysis of 279 013 individuals , 2018, European heart journal.

[2]  M. Visser,et al.  Trunk fat and leg fat have independent and opposite associations with fasting and postload glucose levels: the Hoorn study. , 2004, Diabetes care.

[3]  C. Kooperberg,et al.  Comparison of self-report, hospital discharge codes, and adjudication of cardiovascular events in the Women's Health Initiative. , 2004, American journal of epidemiology.

[4]  F. Azizi,et al.  Effects of obesity on the impact of short-term changes in anthropometric measurements on coronary heart disease in women. , 2013, Mayo Clinic proceedings.

[5]  C. Ayers,et al.  Regional Fat Distribution and Blood Pressure Level and Variability: The Dallas Heart Study , 2016, Hypertension.

[6]  P. Franks,et al.  Abdominal and gynoid adipose distribution and incident myocardial infarction in women and men , 2010, International Journal of Obesity.

[7]  M. Jensen,et al.  Mechanisms and metabolic implications of regional differences among fat depots. , 2013, Cell metabolism.

[8]  J. Ilich,et al.  Aging human body: changes in bone, muscle and body fat with consequent changes in nutrient intake. , 2017, The Journal of endocrinology.

[9]  A. Hoes,et al.  2016 European Guidelines on cardiovascular disease prevention in clinical practice. , 2016, Revista espanola de cardiologia.

[10]  E. Demerath,et al.  Associations between trunk, leg and total body adiposity with arterial stiffness. , 2012, American journal of hypertension.

[11]  Frank B. Hu,et al.  Abdominal Obesity and the Risk of All-Cause, Cardiovascular, and Cancer Mortality: Sixteen Years of Follow-Up in US Women , 2008, Circulation.

[12]  J. Manson,et al.  Association of Body Fat and Risk of Breast Cancer in Postmenopausal Women With Normal Body Mass Index: A Secondary Analysis of a Randomized Clinical Trial and Observational Study , 2019, JAMA oncology.

[13]  Goutham Rao,et al.  Assessing adiposity: a scientific statement from the American Heart Association. , 2011, Circulation.

[14]  M. Jensen,et al.  Normal-Weight Central Obesity: Implications for Total and Cardiovascular Mortality , 2015, Annals of Internal Medicine.

[15]  T. Okura,et al.  Regional Body Composition Changes Exhibit Opposing Effects on Coronary Heart Disease Risk Factors , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[16]  F. Karpe,et al.  Biology of upper-body and lower-body adipose tissue—link to whole-body phenotypes , 2015, Nature Reviews Endocrinology.

[17]  V. Somers,et al.  Differentiating between body fat and lean mass—how should we measure obesity? , 2008, Nature Clinical Practice Endocrinology &Metabolism.

[18]  JoAnn E. Manson,et al.  Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group. , 1998, Controlled clinical trials.

[19]  M D Jensen,et al.  Gender differences in regional fatty acid metabolism before and after meal ingestion. , 1995, The Journal of clinical investigation.

[20]  J. Perry,et al.  Association of Genetic Variants Related to Gluteofemoral vs Abdominal Fat Distribution With Type 2 Diabetes, Coronary Disease, and Cardiovascular Risk Factors , 2018, JAMA.

[21]  L. Lissner,et al.  Does change in hip circumference predict cardiovascular disease and overall mortality in Danish and Swedish women? , 2014, Obesity.

[22]  J. Pell,et al.  The impact of confounding on the associations of different adiposity measures with the incidence of cardiovascular disease: a cohort study of 296 535 adults of white European descent , 2018, European heart journal.

[23]  G. Boysen,et al.  European Guidelines on Cardiovascular Disease Prevention , 2009, International journal of stroke : official journal of the International Stroke Society.

[24]  L. Lissner,et al.  Hip Hip Hurrah! Hip size inversely related to heart disease and total mortality , 2011, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[25]  G. Parati,et al.  Normal weight obesity: a risk factor for cardiometabolic dysregulation and cardiovascular mortality. , 2010, European heart journal.

[26]  G. Hunter,et al.  Regional fat distribution in women and risk of cardiovascular disease. , 1997, The American journal of clinical nutrition.

[27]  Shah Ebrahim,et al.  European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (Version 2012) , 2012, International Journal of Behavioral Medicine.

[28]  F. Schick,et al.  Causes, Characteristics, and Consequences of Metabolically Unhealthy Normal Weight in Humans. , 2017, Cell metabolism.

[29]  S. Fujiwara,et al.  Body composition and development of diabetes: a 15-year follow-up study in a Japanese population , 2018, European Journal of Clinical Nutrition.

[30]  F. Hu,et al.  Total and regional adiposity measured by dual‐energy X‐ray absorptiometry and mortality in NHANES 1999‐2006 , 2016, Obesity.

[31]  B. Zinman,et al.  Are Metabolically Healthy Overweight and Obesity Benign Conditions? , 2013, Annals of Internal Medicine.

[32]  W. Gozansky,et al.  Lower-body adiposity and metabolic protection in postmenopausal women. , 2005, The Journal of clinical endocrinology and metabolism.

[33]  A. Hoes,et al.  [Guidelines on cardiovascular disease prevention in clinical practice]. , 2005, Revue medicale de Liege.

[34]  Nicholas J Wareham,et al.  Body fat percentage, body mass index and waist-to-hip ratio as predictors of mortality and cardiovascular disease , 2014, Heart.

[35]  Claus Christiansen,et al.  Peripheral Adiposity Exhibits an Independent Dominant Antiatherogenic Effect in Elderly Women , 2003, Circulation.

[36]  C. Kooperberg,et al.  Outcomes ascertainment and adjudication methods in the Women's Health Initiative. , 2003, Annals of epidemiology.

[37]  Udo Hoffmann,et al.  Body fat distribution, incident cardiovascular disease, cancer, and all-cause mortality. , 2013, Journal of the American College of Cardiology.

[38]  C. Fall,et al.  Comparison of regional fat measurements by dual-energy X-ray absorptiometry and conventional anthropometry and their association with markers of diabetes and cardiovascular disease risk , 2017, International Journal of Obesity.